TB-Seq, Inc

Convergent Genomics, Inc is a South San Francisco-based company specializing in the development and validation of advanced laboratory-developed tests. Their CLIA-certified and CAP-accredited laboratory ensures the quality and validity of their tests, including the UroAmp test, which has been developed and validated by their expert team. With a focus on clinical expertise and scientific innovation, Convergent Genomics offers a range of products and services for research, collaboration, and partnerships in the field of genomics. Their commitment to quality and precision makes them a trusted provider in the industry.Generated from the website

Founded in 1997, BioCheck develops, manufactures and distributes immunodiagnostic test kits and research reagents. The company has a more than 15,000-square-foot manufacturing facility. It delivers products in Central America, Europe and Asia. BioCheck serves the health care, biomedical, pharmaceutical and scientific research markets. The company also offers antibody conjugation and purification services. Its skilled technicians have experience in microtiter plate coating. The company performs custom immunoassay development for osteoporosis, heart disease, and colorectal and breast cancer. It provides rabbit monoclonal antibodies for research applications with mouse and human Id1, Id2, Id3 and Id4 proteins. The company has received ISO 13485 certification from the International Organization for Standardization. BioCheck additionally offers multiple packaging options.

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information